Status:
COMPLETED
Pharmacist-led Intervention in Treatment Non-adherence in Southwestern Nigeria
Lead Sponsor:
University of Ibadan
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Summary of the Research Medication non-adherence has a huge economic impact on the patient and the society at large. World Health Organization (WHO) has suggested that noncompliance with medication is...
Detailed Description
The study involved adult T2D, hypertensive and those with the two diseases attending the cardiology and endocrinology out-patient clinics of the two tertiary hospitals \[University College Hospital (U...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Adult out-patients diagnosed and being managed for T2D or hypertension or the co-morbid diseases.
- Participants must have been on antidiabetes/or antihypertensive medication(s) for at least six-months prior to their recruitment to the study.
- Exclusion Criteria:
- Newly diagnosed T2D and hypertensive patients
- Pregnant women with diabetes or hypertension.
- Unconscious patients and those booked for admission.
- Patients less than 18 years of age.
Exclusion
Key Trial Info
Start Date :
June 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2018
Estimated Enrollment :
401 Patients enrolled
Trial Details
Trial ID
NCT04712916
Start Date
June 10 2017
End Date
September 20 2018
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College Hospital
Ibadan, Oyo State, Nigeria, 234